Skip to main content
Matthew Schrag, MD, Neurology, Nashville, TN

MatthewSchragMD

Neurology Nashville, TN

Vascular Neurology

Assistant Professor of Neurology

Dr. Schrag is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schrag's full profile

Already have an account?

  • Office

    3601 The Vanderbilt Clinic Neurol
    Nashville, TN 37232
    Phone+1 615-322-3000
    Fax+1 615-936-0605

Summary

  • I run a specialty clinic focusing on cerebral amyloid angiopathy and other microvascular diseases of the brain including CADASIL, Binswanger's disease, COL4a1-vasculopathy, infectious angiopathy and RCVS. My research laboratory focuses on understanding the neurobiology of vascular fragility in cerebral amyloid angiopathy.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Neurology, 2012 - 2015
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Internal Medicine, 2011 - 2012
  • Loma Linda University School of Medicine
    Loma Linda University School of MedicineClass of 2011

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2015 - 2026
  • KY State Medical License
    KY State Medical License 2017 - 2025
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Vascular Neurology

Publications & Presentations

PubMed

Journal Articles

  • Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease  
    Hyun-Sik Yang, Reisa Sperling, Matthew Schrag, Richard Mayeux, JAMA Neurology

Authored Content

  • Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer DiseaseJune 2020

Press Mentions

  • What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
    What Drugmakers Did Not Tell Volunteers in Alzheimer’s TrialsOctober 23rd, 2024
  • New Schizophrenia Treatment; The Increase in Stroke Incidence; TikTok Claims About Mucinex and Pregnancy; Plus Other News Stories with VUMC Sources
    New Schizophrenia Treatment; The Increase in Stroke Incidence; TikTok Claims About Mucinex and Pregnancy; Plus Other News Stories with VUMC SourcesOctober 9th, 2024
  • The New Alzheimer’s Disease Test You Should Know About
    The New Alzheimer’s Disease Test You Should Know AboutAugust 6th, 2024
  • Join now to see all

Other Languages

  • Spanish